Emergent BioSolutions Inc said on Monday it signed a $174 million agreement with AstraZeneca to develop and manufacture the British drugmaker's Covid-19 vaccine candidate.
AstraZeneca in June picked Emergent to help produce the 300 million doses of its potential Covid-19 vaccine pledged to the United States.
(Published 27 July 2020, 11:33 IST)
JOIN US